Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001171843-18-001547
Filing Date
2018-02-28
Accepted
2018-02-28 16:01:02
Documents
90
Period of Report
2017-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 20-F f20f_022818p.htm 20-F 1622469
2 EXHIBIT 12.1 exh_121.htm EX-12.1 9570
3 EXHIBIT 12.2 exh_122.htm EX-12.2 9707
4 EXHIBIT 13.1 exh_131.htm EX-13.1 4307
5 EXHIBIT 13.2 exh_132.htm EX-13.2 4342
6 EXHIBIT 23.1 exh_231.htm EX-23.1 3624
13 GRAPHIC logo.jpg GRAPHIC 38321
14 GRAPHIC kpmg_hdr.jpg GRAPHIC 34576
15 GRAPHIC kpmg_logo.jpg GRAPHIC 3911
16 GRAPHIC mechaction.jpg GRAPHIC 42502
17 GRAPHIC pipeline.jpg GRAPHIC 110703
  Complete submission text file 0001171843-18-001547.txt   6739970

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE FILE cmta-20171231.xml EX-101.INS 1279088
8 XBRL SCHEMA FILE cmta-20171231.xsd EX-101.SCH 92643
9 XBRL CALCULATION FILE cmta-20171231_cal.xml EX-101.CAL 40633
10 XBRL DEFINITION FILE cmta-20171231_def.xml EX-101.DEF 347831
11 XBRL LABEL FILE cmta-20171231_lab.xml EX-101.LAB 371364
12 XBRL PRESENTATION FILE cmta-20171231_pre.xml EX-101.PRE 389880
Mailing Address 4150 ST CATHERINE STREET WEST SUITE 550 MONTREAL A8 H3Z 2Y5
Business Address 4150 ST CATHERINE STREET WEST SUITE 550 MONTREAL A8 H3Z 2Y5 (514) 940-3600
Clementia Pharmaceuticals Inc. (Filer) CIK: 0001647320 (see all company filings)

EIN.: 981128564 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: 20-F | Act: 34 | File No.: 001-38177 | Film No.: 18651028
SIC: 2834 Pharmaceutical Preparations